Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

The fourth cryoballoon generation with a shorter tip to facilitate real-time pulmonary vein potential recording: Feasibility and safety results.

Straube F, Dorwarth U, Pongratz J, Brück B, Wankerl M, Hartl S, Hoffmann E.

J Cardiovasc Electrophysiol. 2019 Jun;30(6):918-925. doi: 10.1111/jce.13927. Epub 2019 Mar 1.

PMID:
30907462
2.

Comprehensive characterization of nanostructured lipid carriers using laboratory and synchrotron X-ray scattering and diffraction.

Tetyczka C, Hodzic A, Kriechbaum M, Juraić K, Spirk C, Hartl S, Pritz E, Leitinger G, Roblegg E.

Eur J Pharm Biopharm. 2019 Jun;139:153-160. doi: 10.1016/j.ejpb.2019.03.017. Epub 2019 Mar 21.

PMID:
30905779
3.

The European COPD audit : Adherence to guidelines, readmission risk and hospital care for acute exacerbations in Austria.

Breyer-Kohansal R, Hartl S, Breyer MK, Schrott A, Studnicka M, Neunhäuserer D, Fülöp G, Burghuber OC.

Wien Klin Wochenschr. 2019 Mar;131(5-6):97-103. doi: 10.1007/s00508-019-1441-5. Epub 2019 Jan 28.

PMID:
30689047
4.

The LEAD (Lung, Heart, Social, Body) Study: Objectives, Methodology, and External Validity of the Population-Based Cohort Study.

Breyer-Kohansal R, Hartl S, Burghuber OC, Urban M, Schrott A, Agusti A, Sigsgaard T, Vogelmeier C, Wouters E, Studnicka M, Breyer MK.

J Epidemiol. 2019 Aug 5;29(8):315-324. doi: 10.2188/jea.JE20180039. Epub 2018 Oct 20.

5.

Long-term outcomes after acute hypercapnic COPD exacerbation : First-ever episode of non-invasive ventilation.

Fazekas AS, Aboulghaith M, Kriz RC, Urban M, Breyer MK, Breyer-Kohansal R, Burghuber OC, Hartl S, Funk GC.

Wien Klin Wochenschr. 2018 Oct;130(19-20):561-568. doi: 10.1007/s00508-018-1364-6. Epub 2018 Jul 31.

6.

Preprocedural Checklist for Magnetic Resonance Imaging Patients Undergoing General Anesthesia: A Process Improvement Plan to Enhance Reimbursement.

Hartl S, Rice AN, Gupta DK, Goode V.

Health Care Manag (Frederick). 2018 Jul/Sep;37(3):205-210. doi: 10.1097/HCM.0000000000000222.

PMID:
29933252
7.

[Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology].

Vogelmeier C, Buhl R, Burghuber O, Criée CP, Ewig S, Godnic-Cvar J, Hartl S, Herth F, Kardos P, Kenn K, Nowak D, Rabe KF, Studnicka M, Watz H, Welte T, Windisch W, Worth H; unter Mitwirkung der folgenden wissenschaftlichen Fachgesellschaften: Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin e.V. ; Deutsche Gesellschaft für Rehabilitationswissenschaften e.V.

Pneumologie. 2018 Apr;72(4):253-308. doi: 10.1055/s-0043-125031. Epub 2018 Mar 9. German.

PMID:
29523017
8.

Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD Audit.

Buess M, Schilter D, Schneider T, Maurer M, Borer H, Thurnheer R, Köhler E, Junker L, Jahn K, Grob M, Rüdiger J, Geiser T, Helfenstein E, Solèr M, Fiechter R, Sigrist T, Brun P, Barandun J, Koltai E, López-Campos JL, Hartl S, Roberts M, Schumann DM, Tamm M, Stolz D.

Respiration. 2017;94(4):355-365. doi: 10.1159/000477911. Epub 2017 Jul 19.

9.

Accuracy of COPD Diagnosis During an Admission: The European Perspective.

Lopez-Campos JL, Castro-Acosta A, Pozo-Rodriguez F, Hartl S, Roberts CM.

Chest. 2017 Jun;151(6):1396-1397. doi: 10.1016/j.chest.2017.01.044. No abstract available.

PMID:
28599931
10.

"Fix Me Another Marguerite!": Species delimitation in a group of intensively hybridizing lineages of ox-eye daisies (Leucanthemum Mill., Compositae-Anthemideae).

Wagner F, Härtl S, Vogt R, Oberprieler C.

Mol Ecol. 2017 Aug;26(16):4260-4283. doi: 10.1111/mec.14180. Epub 2017 Jun 9.

PMID:
28502098
11.

Lessons from individualized cryoballoon sizing. Is there a role for the small balloon?

Hartl S, Dorwarth U, Bunz B, Wankerl M, Ebersberger U, Hoffmann E, Straube F.

J Cardiol. 2017 Oct;70(4):374-381. doi: 10.1016/j.jjcc.2016.12.016. Epub 2017 Feb 16.

12.

Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.

Weiss G, Steinacher I, Lamprecht B, Kaiser B, Mikes R, Sator L, Hartl S, Wagner H, Studnicka M.

NPJ Prim Care Respir Med. 2017 Jan 26;27(1):4. doi: 10.1038/s41533-016-0005-7.

13.

Handling of hazardous drugs - Effect of an innovative teaching session for nursing students.

Zimmer J, Hartl S, Standfuß K, Möhn T, Bertsche A, Frontini R, Neininger MP, Bertsche T.

Nurse Educ Today. 2017 Feb;49:72-78. doi: 10.1016/j.nedt.2016.11.002. Epub 2016 Nov 13.

PMID:
27889581
14.

Supplemental Oxygen During High-Intensity Exercise Training in Nonhypoxemic Chronic Obstructive Pulmonary Disease.

Neunhäuserer D, Steidle-Kloc E, Weiss G, Kaiser B, Niederseer D, Hartl S, Tschentscher M, Egger A, Schönfelder M, Lamprecht B, Studnicka M, Niebauer J.

Am J Med. 2016 Nov;129(11):1185-1193. doi: 10.1016/j.amjmed.2016.06.023. Epub 2016 Jul 15.

PMID:
27427325
15.

Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit.

Ruparel M, López-Campos JL, Castro-Acosta A, Hartl S, Pozo-Rodriguez F, Roberts CM.

ERJ Open Res. 2016 Mar 5;2(1). pii: 00034-2015. eCollection 2016 Jan.

16.

Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?

Hartl S, Lopez-Campos JL.

Eur Respir J. 2016 Jul;48(1):281-2. doi: 10.1183/13993003.00885-2016. No abstract available.

17.

Cryoballoon ablation for persistent atrial fibrillation - Large single-center experience.

Straube F, Hartl S, Dorwarth U, Wankerl M, Bunz B, Ebersberger U, Hoffmann E.

J Cardiol. 2016 Dec;68(6):492-497. doi: 10.1016/j.jjcc.2016.02.007. Epub 2016 Mar 11.

18.

[Non-invasive and invasive out of hospital ventilation in chronic respiratory failure : Consensus report of the working group on ventilation and intensive care medicine of the Austrian Society of Pneumology].

Schenk P, Eber E, Funk GC, Fritz W, Hartl S, Heininger P, Kink E, Kühteubl G, Oberwaldner B, Pachernigg U, Pfleger A, Schandl P, Schmidt I, Stein M.

Wien Klin Wochenschr. 2016 Feb;128 Suppl 1:S1-36. doi: 10.1007/s00508-015-0899-z. German.

PMID:
26837865
19.

Outcome of paroxysmal atrial fibrillation ablation with the cryoballoon using two different application times: the 4- versus 3-min protocol.

Straube F, Dorwarth U, Hartl S, Bunz B, Wankerl M, Ebersberger U, Hoffmann E.

J Interv Card Electrophysiol. 2016 Mar;45(2):169-77. doi: 10.1007/s10840-015-0084-3. Epub 2015 Dec 23.

PMID:
26698157
20.

Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit.

Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B, Roberts CM.

Eur Respir J. 2016 Jan;47(1):113-21. doi: 10.1183/13993003.01391-2014. Epub 2015 Oct 22.

21.

[The Austrian LEAD (Lung hEart sociAL boDy) Study: Background of the Austrian Longitudinal Cohort Study].

Breyer-Kohansal R, Breyer MK, Hartl S, Burghuber OC.

Pneumologie. 2015 Aug;69(8):459-62. doi: 10.1055/s-0034-1392516. Epub 2015 Aug 10. Review. German.

22.

The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit.

Saleh A, López-Campos JL, Hartl S, Pozo-Rodríguez F, Roberts CM; European COPD Audit team.

PLoS One. 2015 Jul 27;10(7):e0134004. doi: 10.1371/journal.pone.0134004. eCollection 2015.

23.

Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit.

López-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM; European COPD Audit team.

PLoS One. 2015 Apr 23;10(4):e0124374. doi: 10.1371/journal.pone.0124374. eCollection 2015.

24.

A review of the value of innovation in inhalers for COPD and asthma.

Virchow JC, Akdis CA, Darba J, Dekhuijzen R, Hartl S, Kobelt G, Roger A, Simoens S, Toumi M, Woodhouse B, Plich A, Torvinen S.

J Mark Access Health Policy. 2015 Sep 16;3. doi: 10.3402/jmahp.v3.28760. eCollection 2015.

25.

Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial.

Köhnlein T, Windisch W, Köhler D, Drabik A, Geiseler J, Hartl S, Karg O, Laier-Groeneveld G, Nava S, Schönhofer B, Schucher B, Wegscheider K, Criée CP, Welte T.

Lancet Respir Med. 2014 Sep;2(9):698-705. doi: 10.1016/S2213-2600(14)70153-5. Epub 2014 Jul 24.

PMID:
25066329
26.

Effects of repetitive peripheral magnetic stimulation on upper-limb spasticity and impairment in patients with spastic hemiparesis: a randomized, double-blind, sham-controlled study.

Krewer C, Hartl S, Müller F, Koenig E.

Arch Phys Med Rehabil. 2014 Jun;95(6):1039-47. doi: 10.1016/j.apmr.2014.02.003. Epub 2014 Feb 19.

PMID:
24561057
27.

Differences in content and organisational aspects of pulmonary rehabilitation programmes.

Spruit MA, Pitta F, Garvey C, ZuWallack RL, Roberts CM, Collins EG, Goldstein R, McNamara R, Surpas P, Atsuyoshi K, López-Campos JL, Vogiatzis I, Williams JE, Lareau S, Brooks D, Troosters T, Singh SJ, Hartl S, Clini EM, Wouters EF; ERS Rehabilitation and Chronic Care, and Physiotherapists Scientific Groups; American Association of Cardiovascular and Pulmonary Rehabilitation; ATS Pulmonary Rehabilitation Assembly and the ERS COPD Audit team.

Eur Respir J. 2014 May;43(5):1326-37. doi: 10.1183/09031936.00145613. Epub 2013 Dec 12.

28.

Variability of hospital resources for acute care of COPD patients: the European COPD Audit.

López-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM; European COPD Audit team.

Eur Respir J. 2014 Mar;43(3):754-62. doi: 10.1183/09031936.00074413. Epub 2013 Aug 29.

29.

European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions.

Roberts CM, Lopez-Campos JL, Pozo-Rodriguez F, Hartl S; European COPD Audit team.

Thorax. 2013 Dec;68(12):1169-71. doi: 10.1136/thoraxjnl-2013-203465. Epub 2013 Jun 1.

PMID:
23729193
30.

[Opinion of the Austrian Society of Radiology and the Austrian Society of Pneumology].

Prosch H, Studnicka M, Eisenhuber E, Olschewski H, Stiefsohn E, Hartl S, Herold C, Burghuber O, Mostbeck G; Vorstände der Österreichischen Röntgengesellschaft, Gesellschaft für Medizinische Radiologie und Nuklearmedizin und der Österreichischen Gesellschaft für Pneumologie; Austrian Society of Radiology; Austrian Society of Pneumology.

Wien Klin Wochenschr. 2013 Jun;125(11-12):339-45. doi: 10.1007/s00508-013-0356-9. Epub 2013 May 15. German.

PMID:
23674050
31.

The European COPD Audit: a pilot experience of 16 European countries.

Hartl S.

Pneumonol Alergol Pol. 2012;80(6):501-4. No abstract available.

32.

Prevalence and prognosis of COPD in critically ill patients between 1998 and 2008.

Funk GC, Bauer P, Burghuber OC, Fazekas A, Hartl S, Hochrieser H, Schmutz R, Metnitz P.

Eur Respir J. 2013 Apr;41(4):792-9. doi: 10.1183/09031936.00226411. Epub 2012 Sep 27.

33.

European COPD Audit: design, organisation of work and methodology.

López-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM; European COPD Audit team.

Eur Respir J. 2013 Feb;41(2):270-6. doi: 10.1183/09031936.00021812. Epub 2012 May 17.

34.

Chronic obstructive pulmonary disease exacerbations: better standards--better prognosis?

Hartl S.

Respiration. 2011;82(4):317-9. doi: 10.1159/000329880. Epub 2011 Jul 19. No abstract available.

35.

Long-term non-invasive ventilation in COPD after acute-on-chronic respiratory failure.

Funk GC, Breyer MK, Burghuber OC, Kink E, Kirchheiner K, Kohansal R, Schmidt I, Hartl S.

Respir Med. 2011 Mar;105(3):427-34. doi: 10.1016/j.rmed.2010.09.005. Epub 2010 Nov 26.

36.

Nordic walking improves daily physical activities in COPD: a randomised controlled trial.

Breyer MK, Breyer-Kohansal R, Funk GC, Dornhofer N, Spruit MA, Wouters EF, Burghuber OC, Hartl S.

Respir Res. 2010 Aug 22;11:112. doi: 10.1186/1465-9921-11-112.

37.

European Respiratory Society MD PhD programme in respiratory science.

Eickelberg O, Laurent G, Nicod LP, Hartl S, Siafakas NM; ad hoc committee.

Eur Respir J. 2010 Aug;36(2):229-30. doi: 10.1183/09031936.00046410. No abstract available.

38.

Incidence and outcome of weaning from mechanical ventilation according to new categories.

Funk GC, Anders S, Breyer MK, Burghuber OC, Edelmann G, Heindl W, Hinterholzer G, Kohansal R, Schuster R, Schwarzmaier-D'Assie A, Valentin A, Hartl S.

Eur Respir J. 2010 Jan;35(1):88-94. doi: 10.1183/09031936.00056909. Epub 2009 Jun 18.

39.

[The effect of one year outpatient pulmonary rehabilitation on patients with COPD].

Zwick RH, Burghuber OC, Dovjak N, Hartl S, Kössler W, Lichtenschopf A, Müller R, Zwick H.

Wien Klin Wochenschr. 2009;121(5-6):189-95. doi: 10.1007/s00508-008-1066-6. German.

PMID:
19412748
40.

Measuring FEV(6) for detecting early airway obstruction in the primary care setting. Quality and utility of the new PiKo-6 device.

Kaufmann M, Hartl S, Geyer K, Breyer MK, Burghuber OC.

Respiration. 2009;78(2):161-7. doi: 10.1159/000197466. Epub 2009 Jan 28.

PMID:
19174602
41.

BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD - a cross-sectional study.

Funk GC, Kirchheiner K, Burghuber OC, Hartl S.

Respir Res. 2009 Jan 9;10:1. doi: 10.1186/1465-9921-10-1.

42.

Comparison of daily physical activity between COPD patients from Central Europe and South America.

Pitta F, Breyer MK, Hernandes NA, Teixeira D, Sant'Anna TJ, Fontana AD, Probst VS, Brunetto AF, Spruit MA, Wouters EF, Burghuber OC, Hartl S.

Respir Med. 2009 Mar;103(3):421-6. doi: 10.1016/j.rmed.2008.09.019. Epub 2008 Nov 9.

43.

Frequency doubled neodymium:yttrium-aluminum-garnet and diode laser-activated power bleaching--pH, environmental scanning electron microscopy, and colorimetric in vitro evaluations.

Goharkhay K, Schoop U, Wernisch J, Hartl S, De Moor R, Moritz A.

Lasers Med Sci. 2009 May;24(3):339-46. doi: 10.1007/s10103-008-0567-x. Epub 2008 May 27.

PMID:
18504640
44.

Expression of prostaglandin E synthase in Barrett's cancer.

von Rahden BH, Stein HJ, Hartl SA, Theisen J, Stigler B, Siewert JR, Sarbia M.

Dis Esophagus. 2008;21(4):304-8. doi: 10.1111/j.1442-2050.2007.00801.x.

PMID:
18477251
45.

Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure.

Funk GC, Lang I, Schenk P, Valipour A, Hartl S, Burghuber OC.

Chest. 2008 Jun;133(6):1354-1359. doi: 10.1378/chest.07-2685. Epub 2008 Mar 13.

PMID:
18339780
46.

Multicentric Adenocarcinomas in a Long-Segment of Barrett's Esophagus.

Hartl S, Siewert JR, Theisen J.

Clin Med Oncol. 2008;2:441-3. Epub 2008 Jun 9.

47.

End-of-life decision-making in respiratory intermediate care units: a European survey.

Nava S, Sturani C, Hartl S, Magni G, Ciontu M, Corrado A, Simonds A; European Respiratory Society Task Force on Ethics and decision-making in end stage lung disease.

Eur Respir J. 2007 Jul;30(1):156-64.

48.

A novel neurotransmitter-independent communication pathway between axons and glial cells.

Hartl S, Heil JE, Hirsekorn A, Lohr C.

Eur J Neurosci. 2007 Feb;25(4):945-56.

PMID:
17331192
49.

Redirection of anthocyanin synthesis in Osteospermum hybrida by a two-enzyme manipulation strategy.

Seitz C, Vitten M, Steinbach P, Hartl S, Hirsche J, Rathje W, Treutter D, Forkmann G.

Phytochemistry. 2007 Mar;68(6):824-33. Epub 2007 Feb 6.

PMID:
17286993
50.

Anti-TNF effects on destructive fibroblasts depend on mechanical stress.

Lange F, Härtl S, Ungethuem U, Kuban RJ, Hammerschmidt S, Faber S, Morawietz L, Wirtz H, Emmrich F, Krenn V, Sack U.

Scand J Immunol. 2006 Nov;64(5):544-53.

Supplemental Content

Support Center